QSIAW Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)0.0% YoY
Profit margin0.0%
Market cap$1.44BSmall cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
-46.4%
Operating margin
-9323.0%
Revenue growth YoY
-69.4%
Dividend yield
Beta
3.17

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About Quantum-Si incorporated

Quantum-Si Incorporated is a pioneering life sciences technology company dedicated to revolutionizing protein sequencing through its proprietary single-molecule technology and advanced quantum dot capabilities. By delivering high-throughput and cost-effective sequencing solutions, Quantum-Si aims to transform protein analysis and accelerate advancements in genomics and personalized medicine. Supported by a robust intellectual property portfolio, the company is strategically positioned to capitalize on the growing demand for innovative sequencing technologies, thus driving substantial progress…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
29 BUSINESS PARK DRIVE, BRANFORD, CT
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$1.44B
Shares outstanding$0
52W high$0.83
52W low$0.02

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer